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ABSTRACT 
 
Milkguard is an alginate-based biosensor developed to detect E. coli in human breast 
milk via the metabolism of X-gal (5-Bromo-4-Chloro-3-Indolyl β-D-Galactopyranoside) 
by β-galactosidase. In order to deconvolute metabolic reproducibility from scaling 
laws, the commercial enzyme β-galactosidase was used to mimic the biological 
function of the bacterial lac operon. Downscaling was explored as an optimization of 
the biosensor design based on numerical solutions to Fickian-based diffusion models. 
The characterization of large capsules (d @ 3 mm) and atomized microcapsules (d @ 
300 ± 60 µm) yielded size-specific Michaelis-Menten constants. Small capsules (Km = 
3.6 x 10-4 M; Vmax’’ = 1.2 x 10-3) produced a significantly faster response time versus 
large capsules when loaded at a substrate concentration of 5 mg/mL (p = 7.7x 10-3 at 𝛼 
= 0.01) and 2.5 mg/mL (p = 1.5 x 10-4 at 𝛼 < 0.001). Comparisons of effectiveness 
factors between small (η = 0.58) and large (η = 0.43) capsules indicates a lesser degree 
of diffusion limitations in small capsules. Large bootstrapping errors produced by 
nonlinear regression of Michaelis-Menten models for the capsules suggests that 
additional mechanisms to diffusion are involved in producing sensor response. A new 
sensor mechanism combining Fickian diffusion and experimental results is proposed 
and modeled numerically. 
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CHAPTER 1. INTRODUCTION 
1.1 Background Motivation 
Breast milk is widely considered to be the gold standard for infant nutrition, offering 
essential nutrients and antibodies that enhance an infant’s health outcomes [1]. 
Breastfeeding lowers the risk of infectious disease during infancy and reduces the 
likelihood of chronic conditions, such as asthma, during early childhood [2]. 
Breastfeeding has also been linked to increased cognitive development[3] and reduced 
infant mortality worldwide [4]. 
 
Despite the benefits of breastfeeding, many mothers may be unable to breastfeed for 
several reasons. Mothers infected with HIV or other bloodborne diseases are advised 
not to breastfeed [5]. Children with metabolic conditions preventing proper digestion of 
breast milk or an inability to latch onto their mother’s breast to feed are also unable to 
obtain sustenance via breast milk [6]. In addition, pumping inaccessibilities due to 
cultural factors also constitutes a barrier to breastfeeding [7]. 
 
These obstacles to breastfeeding has led to a global emergence of breast milk banks 
that increase the accessibility of uncontaminated breast milk for many mothers and 
their infants [8]. Stringent controls have been put in place at these milk banks to ensure 
the safety of milk pumped and donated to these milk banks [9]. After testing the 
mother’s blood for bloodborne disease, donated milk is accepted and pasteurized to 
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reduce the amount of harmful bacteria, followed by culturing by microbiologists to 
confirm the safety of the milk [9]. 
 
The controls put in place to ensure the safety of donated milk, however, are not 
enough to ensure that the levels of bacteria are within safe levels [8]. The 
pasteurization processes conducted by milk banks do not guarantee the complete 
sterilization of breast milk [9]. To confirm that the milk is safe for infant consumption, 
the milk is often sent for bacterial culturing, an expensive, lengthy, and therefore non-
instantaneous process that determines the bacteria content in the milk [9]. These 
processes are not strain-specific, resulting in a high incidence of false negatives. In 
addition, culturing safety criteria is not standardized globally, leading to potential 
variation amongst bacterial content from different milk banks [9]. Therefore, there 
exists a need of a rapid, accurate, sensitive, and affordable method to detect and 
quantify the presence of bacteria in breast milk [8]. Current market solutions to fill the 
need are unable to fit these criteria as previously reviewed [8]. 
 
Previous research efforts have been conducted to address these market needs for a 
rapid, accurate, sensitive, and affordable method to detect and quantify bacteria in 
breast milk [8]. The development of a colorimetric-based biosensor making use of 
encapsulated enzyme substrate in an alginate capsule to detect for the presence of E. 
coli via β-galactosidase, has shown that the previously described four criteria can be 
fulfilled in bacterial sensing [8]. However, the sensitivity of that biosensor could not 
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yield reliable results until approximately eight hours of incubation, a timescale that 
could be reduced with optimization of the sensor [8]. 
1.2 Literature Review 
Solutions on Market 
Current products on the market or under development exist that allow for the detection 
of various components possibly found in milk samples, human or otherwise [8]. These 
products implement different technologies and methodologies in order to produce a 
response to the component the product targets and are intended for commercial, 
research, and home use, depending on the product. Table 1 highlights the variety of 
products available for use [8]. 
Table 1. Diagnostic products and technologies for milk on the market and under development. [8] 
Product  Component Detected  Detection Method  Price  Application Setting  Time  
Happy Vitals [10]  
Macronutrient levels, 
heavy metals, vitamins, 
minerals  
Lab testing by microbiologists  $169.95 - $695.95  
Commercially 
available; lab 
screening of samples 
sent from mothers at 
home  
3-5 days  
Milk Screen by 
Upstring Strips [11] 
Alcohol, Docosahexaenoic 
acid  Colorimetric test strip  
$14.99 for 
eight strips  
Commercially 
available; testing at 
home  
2 minutes  
NeoGen Tests for 
Dairy Products [12]  
β-Lactoglobulin (BLG), 
casein, total milk (casein 
and whey proteins), 
allergens,  
Screening microwell tests, test 
strips, lateral flow strips, 
microwell enzyme-linked 
immunosorbent assay (ELISA) 
tests  
Not 
advertised  
Commercially 
available; used 
throughout production 
process  
30 
minutes  
Soleris System and 
Vials [13] E. coli O157:H7  
Ready-to-use vials with 
colorimetric indicator, incubator, 
and system software  
Not 
advertised  
Commercially 
available; used 
throughout production 
process  
4-24 hours  
Biosensors for 
Quality Assurance of 
Dairy Products [14]  
Nutrients and pesticides  Temperature, light, bacteria  >$1,000  Laboratory research, primarily cow milk  Variable  
Food Biosensors [15] General quality, carcinagen aflatoxin M1  
Optical biosensing of 
chemiluminescence and 
fluorescence detection  
>$1,000  Laboratory research, primarily cow milk  Variable  
Electrochemical  
DNA-based 
biosensor [16] 
Bacillus cereus  
DNA-based Au-nanoparticle 
modified pencil graphite 
electrode (PGE)  
Low  Laboratory Research  Variable  
Poly Methyl 
methacrylate (PMMA) 
“Lab-on-a-chip” [17] 
Energy content as 
measured by fat, protein 
and lactose  
Cross-flow microfiltration 
structure  Low  Laboratory research  
Few 
minutes-
two hours  
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These products, while highly capable, do not fulfill a market need of a low-cost, rapid, 
affordable, biosensor for bacteria in breast milk. However, most notably, colorimetric 
sensors have precedence in the use of component determination in breast milk, 
however not for bacterial detection [18]. Likewise, low cost bacterial sensors do exist, 
albeit for laboratory use [19]. Therefore, the need for a product that fulfills this niche 
exists. 
 
Low-cost alternatives for bacterial detection include paper-based options. Previous 
efforts have produced a paper-based sensor for bacterial detection in dairy milk and 
orange juice [20]. Sensors produced in this manner utilize sol-gel-derived silica inks 
deposited via ink-jet printing to produce a colorimetric response to bacteria. However, 
processing steps that enhance the response of the sensor require specialized 
equipment that are not readily accessible, limiting the use of such sensors. 
 
A low cost paper based sensor for use in breast milk intended to detect E. coli was 
previously developed, making use of X-gal (5-Bromo-4-Chloro-3-Indolyl β-D-
Galactopyranoside) entrapped in sol-gel [21]. These sensors produced a colorimetric 
response to bacteria, with a lower limit of detection at 105 CFU/mL. However, the use 
of a paper-based sensor that implements a lateral flow method for bacterial lysate to 
interact with the entrapped substrate may result in contaminant entrapment, leading to 
further iteration on the sensor design [8]. 
 
 5 
Hydrogels in biosensors 
Biomaterials have a long history of biomedical applications, fulfilling the need to 
replace tissue in and deliver drugs to patients [22]. Hydrogels, a particular class of 
biomaterials, consist of crosslinked macromolecular networks with varying properties 
depending on the intramolecular interactions within the hydrogel and the composition 
of the hydrogel itself [22]. These properties include biocompatibility, porosity, selective 
permeability and resistance to swelling, and biomolecular entrapment and release [23]. 
Consequently, hydrogels are presented as versatile materials that can be modified in 
order to produce a desired response. Hydrogels in biosensors are often used in lateral 
flow strip-type biosensors, such as the aforementioned E. coli sol-gel paper-based 
biosensor and a colorimetric nitrite analysis biosensor that makes use of polyethelyne 
glycol [21]. These biosensors entrap some probe that interacts with a liquid sample in 
order to produce a colorimetric response. 
 
Alginate, a naturally biocompatible, bioinert, low-cost hydrogel, is a strong candidate 
for many biomedical applications [22]. Alginate consists of chains of mannuronic (M) 
and guluronic (G) residues that can be crosslinked using a cation, usually the dication 
Ca2+ [22]. 
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Figure 1. Molecular Structures of Alginate 
 
Alginate is highly modifiable, with many documented methods to tune its properties, 
such as modifying the polymer molecular weight, changing  the ratio of mannuronic to 
guluronic residues, lyophilization, co-polymerization, and modulating crosslinking time 
and/or solution [24]. The implementation of a highly tunable material which can be 
fabricated at low cost is desirable for a biosensor in order to iterate on biosensor 
design in a fairly low-cost manner. 
 
1.3 Current Milkguard Sensor Design 
The Milkguard biosensor, designed by Kikuchi, May, and Zweber, named Milkguard, 
takes advantage of the enzymatic catabolism of X-gal (5-Bromo-4-Chloro-3-Indolyl β-
D-Galactopyranoside) with β-galactosidase, an enzyme produced by E. coli in the 
presence of lactose, a constituent sugar of breast milk [8]. X-gal is encapsulated in an 
alginate sphere crosslinked in a CaCl2 solution and allowed to incubate in a suspension 
containing lysed E. coli that have previously been induced to produce β-galactosidase 
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[8]. Once the capsule is immersed in the lysate, the encapsulated X-gal interacts with 
the bacterial β-galactosidase and produces an indigo-derivative, which appears a blue 
precipitate, indicating the presence of bacteria [8]. This sensor design is documented 
to have a lower limit of detection of 10 CFU/mL [8]. 
 
 
 
Figure 2. X-gal structure and cleavage mechanism. β-galactosidase cleaves the D-lactose structure of X-
gal, yielding galactose and an 5-bromo-4-chloro-3-hydroxyindole (1), which dimerizes and forms 5,5'-
dibromo-4,4'-dichloro-indigo (2) 
 
1.4 Fickian Analysis of Sensor 
Given the design of the sensor, optimization of capsule geometry to allow for enhanced 
release of X-gal may improve sensitivity at shorter timescales. Governing the change in 
concentration of the substrate in the sensor and reaction medium are Fick’s 2nd Law of 
Diffusion and the associated reaction (Equation 1). "[$]"& = 	𝐷𝛻+[𝑆] + 𝑅/  (1) 
where: 
[S] concentration of substrate (M) 
Ri reaction term 
D diffusion coefficient ((m2 s-1) 
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The reaction term follows Michaelis-Menten Kinetics and is derived as follows: 𝐸 + 𝑆	 12341567 𝐸𝑆	 89:&3⎯4𝐸 + 𝑃 (1a) 
where: 
E  enzyme 
S  substrate 
ES  enzyme-substrate complex 
P  product 
K1, k2, kcat reaction constants 
 
⎩⎪⎨
⎪⎧ A$A& = −𝑘1[𝐸][𝑆] + 𝑘2[𝐸𝑆]AF$A& = −(𝑘2 + 𝐾𝑐𝑎𝑡)[𝐸𝑆] + 𝑘1[𝐸𝑆]AMA& = 𝑘2[𝐸𝑆]  (1b) 
 𝑅/ = 	− A$A& = AMA& = 	 NOPP[$]QOR[$]  (1c) 
 
When substituting Ri in Michaelis-Menten Kinetics (Equation 1c) and expanding terms:  "[$]"& = 𝐷S T"5[$]"U5 + 	 +U A[$]AU V − NOPP[$]QOR[$]  (2) 
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where: 
De effective diffusivity     (m2 s-1) 
r distance from center   (m) 
Vm’’ maximum rate of reaction   (mol L-1s-1) 
Km substrate concentration at half Vm  (mol L-1) 
 
Assuming steady state and defining dimensionless parameters 𝑆̅ = 	 [$][$X] 	, 		?̅? = 	 U[ , 	𝛽 = 	 QO[$X], yields the following equation (Equation 3) 
 A5$̅AU̅5 + +U̅ A$̅AU̅ = 𝜙+ $̅^R$̅ _`aaaaa  (3) 
where 𝜙 = 𝑟bNOPP QOcde     (4) 
𝑟f = 𝜂 NOPP[$]QOR[$]    (5a) 
where: 
𝜂 = 𝑓(𝜙) = UijkXlmeUnoee    effectiveness factor (5b) 
 𝜙 gives the Thiele Modulus, the ratio of the rate of reaction to the rate of diffusion 
multiplied to the size of the reaction space. If 𝜂 < 1, then diffusion can be considered a 
rate limiting step. The reaction rate per unit volume, rs, is given by Equation 5. If If 𝜂 = 
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1, then no diffusion limitation exists. rcapsule and rfree are both the n-th order reaction rates 
for their respective conditions. 
 
Based on Equation 2 and the value of the Thiele Modulus, the rate of substrate 
diffusion from the alginate capsule is the only modifiable variable in the system. 
Changing the rate of reaction via catalysis of the reaction is not within the scope of this 
study and will not be considered. Changing the rate of diffusion is of primary focus as a 
method to maximize the sensor’s response. Equation 2 details the inverse 
proportionality between sensor size, r, and the rate of substrate diffusion over time. It is 
hypothesized that reducing the sensor size, r, will in turn increase the rate of diffusion 
over time. Intuitively, the shorter distance the substrate would travel within a smaller 
capsule would allow the substrate to escape the capsule and enter into the lysate to be 
available for reaction. Additionally, the reduction of r would correspond in an increase 
in surface area, given the use of constant volume, due to an increase in capsules that 
can be manufactured. 
 
1.5 Degradation of alginate hydrogels 
A key consideration of alginate hydrogels is degradation of the polymer chains that can 
modify the properties of the hydrogel after crosslinking in a reaction medium. This 
degradation can occur as a result of hydrolysis, oxidation/reduction, photodegradation, 
or enzymatic cleavage [25]. The degradation of a hydrogel can occur either at the 
surface or in bulk, and the occurrence of either is dictated by osmotic 
pressures/swelling. Surface erosion of a hydrogel occurs if the rate of osmosis, or 
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swelling, is slower than the rate of the degradation reaction at the surface, whereas 
bulk erosion occurs if the swelling rate is faster than the surface reaction [25]. It has 
also been documented that the rate of degradation depends significantly on the 
oxidation state of alginate hydrogels [26]. Crosslinker selection, pH, and temperature 
also have effects on the degradation, of alginate hydrogels, as previously documented 
[27, 28].  
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CHAPTER 2. RESEARCH OBJECTIVES AND MAIN ASSUMPTIONS 
2.1 Research Objectives 
Considering the potential improvements to the Milkguard sensor as hypothesized using 
Fickian analysis of substrate diffusion, the following research objectives were 
investigated: 
1. To model substrate diffusion and enzyme kinetics of the -galactosidase and X-
Gal reaction in the reaction space and obtain relevant system-specific reaction 
constants. 
2. To optimize sensor reaction time by scale optimization, specifically by reducing 
sensor diameter by 10-fold. 
These efforts have been made with the overall objective of optimizing the Milkguard 
sensor.  
2.2 Assumptions Made 
The following assumptions have been made when modeling and conducting 
experiments: 
1. The same degree of crosslinking is achieved in all alginate-based structures. 
2. The same X-gal encapsulation efficiency is achieved regardless of encapsulation 
method. X-gal is uniformly distributed within the capsules. 
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CHAPTER 3. MATERIALS AND METHODS 
3.1 Materials 
X-gal (5-Bromo-4-Chloro-3-Indolyl β-D-Galactopyranoside; Thermo Fisher; Waltham, 
MA, USA; B1690, Lot #1899771) was used as the β-galactosidase substrate. β-
galactosidase (A. orizae; Sigma Aldrich; St. Louis, MO, USA; 10.3 U/mg, G5160-
125KU, Lot #SLBB6762V). was also used and suspended in phosphate buffered saline 
(PBS, pH = 7.2; Sigma Aldrich; St. Louis, MO, USA; 319252-2L, Lot #SHBD0394V).  
The Milkguard sensor was fabricated using medium viscosity (MV) sodium alginate 
(Thermo Fisher; Waltham, MA, USA; A2033-500G, Batch# 108K1228) dissolved in a 
0.9% w/v NaCl (saline) solution (Sigma Aldrich, Inc. S5886-1KG, Lot # 081M00921V). 
Sensors were cross linked in a 1.5% w/v CaCl2 solution (VWR Analytical; Radnor, PA, 
USA; BDH9224.1, Lot #1384C509).  
 
3.2 Sensor Fabrication 
Alginate Mixture 
Considering the aqueous conditions of alginate capsule fabrication and storage, it is 
likely that complete dissolution of XG is impossible. To minimize the variability in 
testing the capsules moving forward, dissolution of XG in dimethylformamide was not 
considered for testing. This decision was made in order to prevent changes in the 
chemistry of the β-galactosidase/XG reaction. Likewise, this decision was made in line 
with previously reported results that found that XG did not need to be completely 
dissolved in order for the sensor to work as intended [8]. Therefore, saline was chosen 
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as the solvent of choice to prepare the hydrogel. 
 
 Drop-based sensors (large sensor/bead/capsule, macrocapsule] 
2% w/v sodium alginate was dissolved in 0.9% w/v saline and stirred for 24 hours. The 
hydrogel was autoclaved for 20 minutes at 120 ºC and allowed to cool to room 
temperature. After reaching room temperature, X-gal (XG) was mixed into the hydrogel 
and the resultant solution stirred for 24 hours. Alternately, the alginate-XG mixture was 
vortexed vigorously to ensure a thorough, uniform distribution of XG. After sufficient 
stirring, 3 mL of alginate were crosslinked dropwise using a 161/2 G needle into a 1.5% 
w/v CaCl2 bath for 30 minutes. [8] After the crosslinking period, the alginate beads (also 
referred to as “sensors”, “large capsules”) were rinsed three times using 0.9% w/v 
saline [8]. One sensor, measuring approximately 3 mm in diameter would then be 
placed into an Eppendorf tube or reaction well.  
 
Atomization of Sensors (small sensor/bead/capsule, microcapsule) 
2% w/v medium viscosity alginate was autoclaved at 121 ºC for 15 minutes and left to 
rest to reach room temperature. After reaching room temperature, XG was mixed into 
the alginate for 24 hours or vortexed vigorously. 1 mL of alginate was jetted using a 
coaxial needle (24G/16G; FA = 1.5 L/min, FL = 0.7 mL/min) into a 1.5% w/v CaCl2 bath 
from a height of 3 cm [29]. The atomized microcapsules were left to crosslink for 20 
minutes before rinsing with saline. The suspension was transferred to a 15 mL 
centrifuge tube and the sensors left to settle. Microcapsules were obtained by pipetting 
a suspension from the tube, and capsules were verified to have been transferred via 
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phase-contrast microscopy.  
 
3.3 Protein Suspension Preparation and Enzymatic Assay 
Dilutions of alginate were made at 5, 2.5, 2, 1, 0.5, 0.25, 0.125, and 0 mg XG/mL and 
crosslinked to form both large and small capsules. β-galactosidase from A. oryzae was 
suspended in a PBS solution to create a 2.5 U/mL suspension. 50 µL of this 
suspension was aliquoted to a well of a 96 well plate containing one large capsule or 
56 µL of prepared small sensor suspension. 56 µL was approximated to be sufficiently 
equivalent in volume to one large bead given the dimensions of atomized capsules to 
account for the transfer of residual saline. The enzymatic reaction was monitored, and 
absorbance was measured at 615 nm. 
 
3.4 Statistical Testing 
Statistical comaprision of the samples was conducted in MATLAB 2018b using a one-
sided, two-sample Student’s t-test with a repetition size of 5 (n = 5) at various 
confidence intervals [30]. 
 
Assuming unequal variance:  𝑡 = 	 (pa2qpa5)bX25r2RX55r5 (6a) 
where: 
 16 
s sample standard deviation 
degrees of freedom: 
sX25r2RX55r5t52(r2u2)sX25r2t5R 2(r5u2)sX55r5t5  (6b) 
 
3.6 Concentration Determination from Absorbance 
Absorbance data was taken every 15 minutes at 615 nm (n = 5) using an infinite 
m200PRO (Tecan; San Jose, CA, USA) plate reader and iControl 1.8 software (Tecan; 
San Jose, CA, USA). Beer-Lambert’s Law was used to establish the concentration of 
the product formed using the measured absorbance values. Using an extinction 
coefficient of ε = 19,942 M-1 cm-1 and a path length of 2 mm [31], the Beer-Lambert 
Law equation yields the following (Equation 7): 𝐴 = 	𝜀𝑙𝑐  (7) 
where  
A Absorbance 
ε Extinction coefficient (M-1 cm-1) 
l path length (mm) 
c concentration (M) 
Upon substitution of the constants and algebraic rearrangement of Equation 7, the 
following is determined. 𝐶 = 	 z{.}~~	u2 (8) 
This relationship holds only for absorbance values < 1. 
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3.5 Non-linear regression 
Non-linear model regression using the Simplex Method was performed using 
Matlab18b (Mathworks, TX, USA)  to determine the kinetic coefficients of the 
Michaelis-Menten model.  Non-linear error analysis was conducted using the 
bootstrapping technique, where 10 datasets were created using a Monte Carlo 
simulation from the original dataset. The ten sets of best-fit values for the parameters 
of the model as well as the covariance matrix containing the standard deviation for 
each parameter will be reported. 
 
The estimated covariance between the ith and jth model parameter: Σ/+ = 𝑠+ = ^q^∑𝑥/𝑥 − 𝑥/	𝑥 i,j = 1, 2, …, n  (6c) 
 
3.6 Numerical Simulations 
COMSOL 5.3 (COMSOL, Inc.; Stockholm, Sweden) was used to perform time 
dependent simulations on small and large capsules. The unsteady state partial 
differential equations were solved numerically at specified initial and boundary 
conditions outlined in the respective section. 
 
3.7 Capsule Visualization and Size Determination 
Capsules were visualized via phase-contrast microscopy and image capture were 
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performed using the Olympus CKX53 microscope in conjunction with the Olympus 
cellSens platform (Olympus; Waltham, MA, USA). Measurements were made using the 
software’s built in ruler. Average diameters were calculated using the diameters of 10 
capsules. Capsules were visualized in saline buffer, reaction medium, or out of buffer. 
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CHAPTER 4. RESULTS AND SIMULATIONS 
4.1 COMSOL Modeling of Original Milkguard Sensor 
The original sensor developed by Kikuchi, May, and Zweber in 2018 [8] was modeled in 
2D based on the additional assumption that β-galactosidase only reacted with XG 
outside of the bead. To simulate the surface reaction and the change in concentration 
of the substrate over time, time-dependent simulations were generated.  
 
Figure 3. COMSOL 5.3  simulation geometry for reaction space. The reaction well is represented by a 
square, and contains a bead settled at the bottom due to gravity. The circle is 3 mm in diameter to reflect 
the average size of the sensor. The well is approximately the same size as a single well of a 96-well, flat 
bottom plate. 
To solve Equation 1, boundary conditions were necessary to define in accordance to 
several assumptions in regards to previous experimental observation [8]. 
 
The concentration of substrate was assumed to remain constant at the center of the 
capsule. Additionally, the initial substrate concentration, Co, was considered to be 1 
mol/m3. Actual sensors had a variable molarity; therefore, to mitigate the variation in 
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substrate concentration, concentrations were considered to be normalized onto a 
scale from 0 to 1. At the edge of the bead, the concentration was assumed to be 95% 
that of the initial concentration (or 0.95Co) to account for the loss of substrate at the 
membrane of the bead during storage or transfer between media. Diffusivities are 
shown as follows: 
Table 2. Key COMSOL Simulation Parameters [29, 32] 
Parameter Value 
Dmembrane^ 1.12 x 10-13 m2/s 
Dcore& 1 x 10-12 m2/s 
Dwell# 6.5 x 10-10 m2/s 
kcat 0.0001 s-1 
h 0.25 
^ Defined as the region at the periphery of the 
capsule, 10 µm in width 
& Defined as the bulk region of the capsule 
# Defined as reaction space outside of the capsule  
 
Ri from Equation 1 was defined by the expression -hkcatC to reflect the diffusion 
limitation of the substrate. kcat is representative of bacterial kinetics as previously 
shown [32]. 
 
The boundary conditions are defined as follows: 
- Initial Condition: At t = 0, C(x,t) = Co 
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- Boundary Condition 1: At x = 0, 𝑑𝐶 𝜕𝑥`  = 0 
- Boundary Condition 2: At x = R, C = 0 for all t > 0 
- Boundary Condition 3: At x = L, C = 0 for all t ≥ 0 
The reaction space, defined by the square, was assumed to be self contained; 
therefore, no flux was defined at the edges of the space (Boundary Condition 3). The 
initial concentration of substrate in the well and at the perimeter of the capsule was 
defined to be 0 (Boundary Conditions 1 and 2). 
 
If the capsule is uniform, then it can be assumed that no concentration gradient exists 
as θ (polar angle) or φ (azimuthal angle) changes. Therefore, Fick’s 2nd Law (Equation 1) 
can be simplified and solved as a 1D equation dependent only on the distance 
travelled. At steady state, where 𝑑𝐶 𝜕𝑥`  = 0, the solution can be solved as Equation 2. 
For a given control volume, solving this differential equation yields the following 
solution (Equation 9): 𝐶(𝑥, 𝑡) = 𝐶erfc T +√d&V (9) 
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Figure 4. COMSOL 5.3 model of substrate diffusion and enzyme reaction in large capsule. Color 
gradient represents substrate concentration at (A) 0 seconds, (B) 2400 seconds, (C) 5400 seconds, (D) 
8400 seconds. (E) Line graphs depicting substrate depletion from the center of the bead to the edge of the 
reaction space over time. 
 
 
Figure 5. COMSOL 5.3 model of substrate diffusion and enzyme reaction in proposed atomized beads. 
Top: Color gradient represents substrate concentration at (A) 0 seconds, (B) 2400 seconds, (C) 5400 
seconds, (D) 8400 seconds. (E) Line graphs depicting substrate depletion from the center of the bead to 
the edge of the reaction space over time. 
The hypothesis outlined in Research Objective 1 was confirmed by the simulation. 
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Given the same volume, smaller beads have a higher surface area compared to larger 
beads. This simulation depicts the performance of a single bead; therefore, the volume 
of the small beads requires hundreds of individual capsules to match the volume of a 
single bead, enhancing the effect seen by the simulation. For example, at a time point 
of 2400 s and an arclength of 0.002, the dimensionless substrate concentrations are 
0.7 and 0.15 for the large and small capsule respectively. 
 
4.2  Sensor Visualization and Morphology 
Beads were visualized using phase-contrast microscopy (Figure 6 and 7) in order to 
verify the size of microcapsules after crosslinking and to confirm successful 
encapsulation of XG in both small and large capsules. Initially, it was believed that the 
vigorous mixing of XG in alginate over a long period of time would be sufficient to 
ensure uniform distribution of XG within the capsule. Therefore, it was assumed to 
dissolve completely with lengthy and sufficient mixing, leading to the hypothesis that 
there would be no visual difference between an empty (XG-) capsule and an 
alginate/XG (XG+) capsule. 
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Visual confirmation of XG was made possible due to the presence of dark crystalline 
structures of XG in the XG+ capsule. It has been previously reported that XG is soluble 
in organic solvents like dimethyl formamide (DMF) and sparingly soluble in aqueous 
buffer (with a reported solubility of 0.5 mg/mL in a 1:1 solution of DMSO:PBS) [33].  
Atomized XG-loaded and empty capsules with an average diameter of 300 µm are 
illustrated in Figures 7A and 7B, respectively. 
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Figure 7. Phase-contrast microscopy of XG-loaded alginate microcapsules in saline (0.9%) buffer. 40X 
magnification, scale bar 200 µm.(A) [XG] = 5 mg/mL. XG crystals are present as jagged aggregates with 
high contrast relative to the capsule. (B) [XG] = 1 mg/mL. No XG was observed in the saline buffer.  
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Within the beads were visible crystals of XG, showing that XG could be successfully 
encapsulated in beads crosslinked via atomization. The saline storage solution for the 
microbeads was also visually inspected to ensure that no XG was present in the buffer. 
The volume of 1 microcapsule with a diameter of 300 µm is approximately 0.014 µL. To 
match the volume of 1 macrocapsule with a diameter of 3 mm and corresponding 
volume of 14.1 µL, it was assumed that 56 µL of microcapsule suspension was 
sufficient to match the volume of a single microcapsule. A volume four times that of a 
single bead was deemed to be necessary in order to account for excess saline and 
variations in microbead size. A summary of the findings are presented in Table 3. 
Table 3. Comparative Geometric Dosage of Milkguard Sensors. 
Property Large Capsule Small Capsule 
Average Diameter (mm) 3 0.300 ± 0.060^ 
Surface Area (mm2) 28.3 0.28 
Volume (mm3) 14.1 0.014 
Surface Area:Volume 2 20 
Units per sensor# 1 1000 
Effective Surface Area (mm2) 28.3 280 
 
#Defined as the number of individual sensors whose sum volume is equivalent to a single large capsule of 
diameter 3 mm. 
^Standard Deviation determined at n = 15 
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4.3 Enzymatic Assay of β-galactosidase on micro- and macroencapsulated XG 
Shown in Figure 8 is the progression of the assay using free and encapsulated XG at 
15 minute intervals. As seen in Figure 8A the blue intensity of the well plate progresses 
the fastest in wells with free XG and the slowest in wells with a large capsule. Figure 8B 
quantifies the absorbance at 615 nm of each well, and statistically significant 
differences between small and large capsules was identified in capsules containing 5 
mg/mL (p = 7.7x 10-3 at 𝛼 = 0.01) and 2.5 mg/mL (p = 1.5 x 10-4 at 𝛼 < 0.001). 
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Figure 8. (Continued on next page) 
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Figure 8. Absorbance of XG product. (A)  Images of assay plates taken over time. Top plate: free 
substrate; Middle plate: small capsules; Bottom Plate: large capsules. Within each plate, prepared 
sensors containing variable amounts of XG were placed in individual wells, with n = 5 for each 
concentration. Absorbances for each condition were taken every 15 minutes.  (B) Absorbance at t=180 
minutes at 615 nm, error bars at 95% confidence (N = 5). T-testing of absorbance values between small 
and large capsules found significane between the small and large capsules at 99% confidence (**) at 5 
mg/mL and 99.9% confidence (***)  at 2.5 mg/mL 
Based on Figure 9, data to model enzyme kinetics includes all values up to and 
including the data taken at 105 minutes. This region was chosen due to absorbance 
remaining < 1 for all conditions by this time, as well as the linear trend seen up to that 
point, in order for Beer-Lambert’s Law to hold for concentration determination. 
 
Figure 9.  Absorbance over time for free XG. Standard error for all timepoints is negligible. For all 
conditions, absorbance < 1 up to 105 minutes. After that point, Beer-Lambert’s Law does not hold 
Shown in Figures 10A and 10B are the Michaelis-Menten and Lineweaver-Burke (LB) 
plots using which the kinetic constants were determined and reported in Table 4. Due 
to the poor linear fit as reflected by the linear regression coefficient (R2 = 0.00005) of 
the LB plot for the large capsules, the values of the kinetic constants are not reported. 
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Based on the concentration values (in M) calculated from the absorbance 
measurements (Appendix 1), the reaction rate was calculated for each corresponding 
concentration of XG substrate. Those reaction rates were plotted against their 
corresponding XG concentration to generate a Michaelis-Menten plots. (Figure 10A). 
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Using a Lineweaver-Burk model, linear regression was performed to determine the 
kinetic constants Km and Vmax for the reaction.  
Table 4. Kinetic Constants for Milkguard Sensor Reaction 
Metric Free XG Small Capsule Large Capsule 
Km/Vmax 0.31 0.82 2.15 x 103 
1/Vmax 8.47 x 102 1.10 x 10 3 1.00 x 10-5 
R2 0.89 0.71 5.00 x 10-7 
Km (M) 3.60 x 10 -4 7.50 x 10-4 N/A 
Vmax (M/min) 1.18 x 10-3 9.10 x 10-4 N/A 
 
The kinetic constants determined by this analysis reveal comparative activities 
between the free substrate and the small capsule. Of note is the difference in Vmax 
between the conditions, indicating a difference in response time for the sensor when 
compared to free solution. 
 
Nonlinear regression and error analysis of concentration data via the simplex method 
and bootstrapping technique was conducted as previously mentioned using the 
Lineweaver-Burk constants as initial guesses. Results are summarized in Table 6.  
 
Table 5. Kinetic Constants for Milkguard Sensor Reaction obtained by Nonlinear Regression, Simplex. 
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Metric Free XG Small Capsule 
Km (M) 4.20 x 10-4 7.80 x 10-4  
Km 
bootstrapping 
Error 
1.72 1.14 
Vmax (M/min) 1.20 x 10-3 9.60 x 10-4 
Vmax 
bootstrapping 
error 
0.20 0.13 
 
Table 6. Effectiveness Factor for Small and Large Capsules. 
Metric Small Capsule Large Capsule 
η  0.58 0.43 
 
High bootstrapping errors in the nonlinear regression (Table 5) performed indicate a 
poor fit for all sensor conditions, suggesting that the reaction mechanism is not solely 
due to Michaelis-Menten enzyme kinetics, indicated by sharp increases in rate at high 
concentrations for the small capsule condition. (Figure 10A). The effectiveness factors, 
η, (Table 6) were calculated to be 0.5769 for small capsules and 0.4313 for large 
capsules, assuming first order kinetics using the first 4 points of each reaction dataset.   
4.4 Sensor and Reaction Medium Stability 
To determine if degradation plays a significant role in the rate of reaction, beads were 
imaged after 60 minutes of incubation with the enzyme, and visually inspected for a 
blue coloration. Microbeads were examined and there was no indication of surface 
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erosion or bulk degradation. Large capsules were inspected and there was no 
significant change in morphology at the surface. Of note is the presence of a “halo” 
around the capsule (Figure 11B) Examinations of both sets of capsules did not identify 
any free XG in the reaction buffer. However, the presence of an unknown precipitate 
was identified in the reaction medium. 
 
Figure 11. Large sensor capsule stability and reaction mechanism images.  (A) Large alginate bead 
+XG in saline; (B) Large alginate bead + XG incubating in enzyme suspension; (C) Aggregates of 
uncharacterized species are present in solution; (D) and (E) Large alginate beads incubating in enzyme 
at 0 minutes (D) and 15 minutes (E). (F) Small alginate beads + XG in an enzyme suspension at t = 72 
hours. 
The unknown species appeared after some time had passed in the incubation and 
were not previously observed in the crosslinking solution, the enzyme suspension, and 
the crosslinking wash. Additionally, observation under microscope confirms that the 
species are not XG crystals or aggregates, as their morphology is different than that of 
free XG. Further characterization of the aggregates is needed in order to determine 
their impact on the reaction and/or quantification of relevant metrics. To determine the 
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rate of reaction in the capsule, individual large capsules were removed from the 
reaction medium, bisected and observed (Refer to Appendix 3). A faint blue coloration 
was observed at the periphery of the alginate hemisphere, indicating that the reaction 
was first taking place at the capsule membrane and proceeding inward. After some 
time, the bisected capsules were observed to have continued to change color outside 
of the reaction medium. To account for excess protein that may have remained on the 
surface of the capsule, the same behavior was observed even after the capsule had 
dried, with the capsule fragments turning as intensely blue as the intact capsules in the 
suspension 24 hours after the incubation had started. 
 
Figure 12. Bisected sensor and long term reaction results. (A) A bisected large alginate + XG bead 15 
minutes after incubation. A faint blue hue can be observed at the edge of  the sphere. (B) Large alginate 
+ XG beads in the enzyme suspension 24 hours after initial incubation.  
 
4.5 Proposed Mechanism of Action 
Observation of the capsule morphology has revealed that using current capsule 
fabrication methods and materials produces capsules with undissolved XG 
encapsulated within the crosslinked hydrogel sphere. Furthermore, the solubility of XG 
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in aqueous solution is relatively low, with discrete particles or crystals of XG present at 
a microscopic level. Based on these observations, it is theorized that previous 
assumptions of substrate uniformity in the capsule are made invalid. In theorizing the 
mechanism of reaction, several key assumptions are incorporated based on 
experimental observation. First, XG is assumed to be unable to diffuse outward from 
the alginate capsule. This assumption is based on the observed crystals of XG still 
present in the capsule after 24 hours of observation and the lack of crystals in the 
supernatant. Second, degradation of the alginate capsule is assumed to be negligible 
based on the inspection of incubated capsules after long periods of time. Third, the 
alginate capsule is permeable to β-galactosidase. Previous research in the 
characterization of the molecular weight cutoff of alginate has identified 500 kDa as the 
upper bounds of permeability for a nanoparticle [34, 35]. β-galactosidase has a 
molecular weight of 464 kDa, within the reported molecular weight cutoff of alginate 
[36]. Fourth, the mechanism must account for the calculated Vmax and Km. 
 
Assuming these assumptions to be true, protein diffusion into the alginate capsule is 
likely occurring and serving as the driving force behind sensor response, leading the 
interior of the capsule to be the main reaction space. When the sensor is introduced 
into the enzyme suspension, the proteins adsorb on the surface and react with any XG 
present at the surface of the membrane. At some point, due to the saturation of 
proteins at the surface, a concentration polarization effect is present, preventing the 
diffusion of the protein result in the phenomenon described in Figure 11B. 
Consequently, the rate of diffusion, and therefore reaction, are limited, especially 
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towards the beginning of the reaction. Thus, diffusion, while a rate limiting step, is not 
the sole major phenomenon responsible for the behavior seen in the experimental 
assays. Nonetheless, due to the lack of enzyme encapsulated in the sensor, a 
concentration gradient exists between the suspension and the capsule, driving 
diffusion of the enzyme into the sensor. Movement of the enzyme is possible into and 
within the alginate capsule due to the porosity of the alginate capsule. As the alginate 
moves from the reaction medium to the alginate, the diffusivity changes from the 
reaction media (aqueous) to that of the alginate hydrogel [34]. With changes in the 
diffusion coefficient, the movement of the protein through the reaction space is likely to 
be hindered compared to its movement in aqueous solution. Thus, the size 
dependency as dictated by Fick’s 2nd Law results in differences in the rate of the 
change of protein concentration. Given the smaller size of the alginate microcapsule, 
the rate of protein diffusion is much higher than that in the larger capsules. When 
considering the substrate, the diffusion of XG crystals is limited due to its solubility in 
aqueous solution; therefore, most enzyme-substrate reactions occur within the 
capsule. The enzyme metabolizes the XG within the capsule, and the dimerization of  
5-bromo-4-chloro-3-hydroxyindole to 5,5'-dibromo-4,4'-dichloro-indigo can occur 
within the capsule or in the supernatant. Indigo derivatives are sparingly soluble in 
aqueous solution (900 µg/mL), so the diffusion of the indigo subunits and dimer is 
possible, accounting for the change in color of the supernatant. 
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4.6 Modified Numerical Simulation of Milkguard Sensor 
Given the nature of the proposed mechanism, a modified simulation detailing the 
mechanism of sensor action was created. Based on the current sensor COMSOL 
model, the modified COMSOL simulation features geometries that mimic the XG 
substrate crystals seen in micrographs of the capsules. Thus, the simulation tracks the 
change in free protein concentration due to diffusion and reaction. This simulation does 
not track the concentration of protein-substrate complexes, but the reaction constants 
incorporate the association and dissociation of such complexes as shown in Equation 
1b. Key parameters for the simulation are detailed as follows (Table 7) [29].  
Table 7. Modified COMSOL simulation parameters 
Parameter Value 
Dmembrane^ 9.45 x 10-13 m2/s 
Dcore& 7.31 x 10-10 m2/s 
Dsubstrate# 5.00 x 10-12 m2/s 
K (M) 3.60 x 10-4 
Vmax (M/min) 1.18 x 10-3 
^ Defined as the region at the periphery of the 
capsule, 10 µm in width 
& Defined as the bulk region of the capsule 
# Defined as circular regions representing substrate. 
Diffusivity is arbitrarily chosen. 
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Figure 13. Proposed COMSOL model of Milkguard Sensor. Protein concentration is represented by the 
red-blue gradient. (A) t= 1800 seconds; (B) t = 3600 seconds; (C) t = 5400 seconds; (D) t = 5400 
seconds; (E) 1D concentration plot over bead diameter  
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CHAPTER 5. DISCUSSION 
This work has changed perception of the mechanism by which the Milkguard sensor 
operates and clearly identifies the effects that downscaling will have on the overall 
sensor response. Downscaling the sensor produces a response at a faster rate 
compared to sensors that have been produced previously. This is made most apparent 
by the absorbance data in present in Figure 8. After an extended amount of time, the 
absorbance of each sample is significantly higher in the smaller capsules when 
compared to the larger capsules at higher concentrations ( 5 mg/mL: p = 7.7x 10-3 at 𝛼 
= 0.01; 2 mg/mL: p = 1.5 x 10-4 at 𝛼 < 0.001). in the small beads. This effect matches 
the predictions made using Fick’s 2nd Law of Diffusion. Instead of considering the 
substrate concentration as a function of space and time, protein diffusion is the subject 
of analysis by Fickian laws. Consider that the inward diffusion of β-galactosidase is 
governed by the following equation (10): 
 ""& = 𝐷S T"5"U5 + 	 +U AAUV  (10) 
where:  
C β-galactosidase concentration (M) 
De diffusion coefficient (m2 s-1) 
r distance from membrane to the capsule’s center (m) 
 
Downscaling the sensor reduces r, and via the inverse relationship between r and 𝜕𝐶 𝜕𝑡`  , the concentration change of the enzyme is predicted to change more rapidly 
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over time as the distance needed to travel decreases. The implications of this effect on 
the sensor are substantial, as more XG can be made available for the enzyme as it 
diffuses inward toward the capsule. An inverse relationship between the area of the 
membrane and the change in protein concentration becomes apparent. The effective 
surface area of the microcapsule sensors is approximately 10-fold that of a single large 
capsule. Therefore, it can be deduced that the change in protein concentration at a 
given point in the smaller sensors occurs at a rate 10 times that of the larger sensors. 
Experimental determination of protein concentration throughout the sensor for the 
duration of the reaction can confirm if this prediction based on Fickian analysis is 
correct; however the quantitative nature of the undertaking is outside of the scope of 
this project.  
 
The proposed sensor mechanism is one possible explanation for the behavior seen 
when incubated in an enzyme suspension. However, this proposal is merely a 
hypothesis and not a definitive explanation for the operation of the sensor. Several key 
points must be addressed with the proposed mechanism to confirm, refine, or 
invalidate it. First, verification of the enzymatic constants is required. The behavior 
seen in the Michaelis-Menten modeling of the capsules does not seem to be ideal 
given the observed color change at each substrate concentration. Second, the 
visualization of protein diffusion is near impossible given the solubility of the enzyme 
under these conditions. Therefore, there is no experimental method to verify that the 
proteins are capable of diffusing into the capsule and producing a gradient as modeled 
by Fickian diffusion. Third, the formation of the aggregates must be addressed, as their 
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composition and effect on the reaction are unknown at this time. It is hypothesized that 
these aggregates are indeed β-galactosidase units. Additionally, the formation of a 
“halo” around the capsule may indicate that adsorption and concentration polarization 
are additional effects in the mechanism of the system. However, their effects on the 
reaction are not incorporated in this model and are outside of the scope of this effort. 
Fourth, it is unclear if this mechanism is generalizable to other enzymatic reactions. 
Due to the nature of the sensor and the range of bacteria needed to be detected in 
breast milk [8], additional characterization must be completed on other analogous 
enzymatic reactions. 
 
Of most importance, this work documents the effect that downscaling has on the 
Milkguard sensor for producing a more rapid response. These effects have been 
observed in a reaction medium containing β-galactosidase suspended in PBS. These 
effects, while beneficial to understanding the sensor‘s behavior in the presence of an 
idealized reaction medium, have not been yet documented in a simulated 
contaminated breast milk sample. While the large capsule design has been previously 
shown to work for such conditions [8], the effect of atomized alginate-XG capsules has 
not been documented nor compared against the large capsules. Work to establish a 
direct comparison between the two sizes must be conducted to show increased 
efficacy and higher response time with downscaling. 
 
It is to be noted that the degree of crosslinking in the capsules, both large and 
atomized has not been determined in this work. Given the difference in crosslinking 
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time between both sensor sizes, there exists the potential for nonuniform hydrogel 
mechanical properties, assuming crosslinking from the same batch of alginate. 
Crosslinking times were chosen based on assumed uniformity given the change in size 
of the beads [35]. Thus, rheological characterization of the beads is yet to be 
completed.   
 
A preliminary effort has been initiated to deconvolute the effects of the surface 
reaction, bulk diffusion, and inward protein diffusion. A cationic chitosan-based 
adsorption layer encapsulating XG immobilized on the surface of an empty alginate 
bead would quantify surface reactions versus intracapsule detection. (Refer to 
Appendix 2). 
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CHAPTER 6. CONCLUSION 
The Milkguard alginate-based biosensors have been characterized. Michaelis-Menten 
constants specific to each capsule design were determined for β-galactosidase in the 
Milkguard sensor. The minimum recommended incubation times for large capsules  
(d ~ 3 mm) and microcapsules (d ~ 300 µm) are 180 minutes and 120 minutes, 
respectively, at a substrate concentration of 1 mg/mL. The reaction rates for both 
Milkguard sensor designs were characterized. Atomized capsules show significantly 
faster responses as shown by the magnitude of the absorbance data, difference in 
enzymatic constants, and the value of the effectiveness factor (hlarge = 0.4313 ; hsmall= 
0.5769). Based on experimental observation of sliced macrocapsules over time, an 
inward protein diffusion model for the Milkguard sensor has been proposed. 
Additionally, a numerical simulation depicting the diffusion and reaction of the enzyme 
and enzyme-substrate complexes has been proposed. Downscaling the sensor has 
several implications for the future development of the sensor, influencing the direction 
that future research efforts should undertake. Expanding the sensor miniaturization 
scope to bacterial detection, several strains need to be tested in order to assert the 
their respective sensitivities and lower limits of detection [37]. The benefits that an 
increased sensor response time for bacterial detection can provide easier and 
affordable testing for bacteria in breastmilk, granting access to the gold standard of 
nutrition for more infants worldwide. 
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CHAPTER 7. APPENDIX 
Appendix 1. Data 
Table A1.1 Absorbance Data 
 
 
 
 
Free Enzyme Time (minutes) 
[XG] 
(mg/mL) 15 30 60 75 90 105 120 135 150 165 180 
5 0.762 0.743 0.862 0.657 0.903 0.996 1.159 1.016 1.455 1.374 1.553 
2.5 0.307 0.353 0.471 0.441 0.476 0.655 0.737 0.762 1.096 1.012 0.951 
2 0.356 0.424 0.548 0.527 0.513 0.601 0.657 0.760 0.888 0.988 1.069 
1 0.182 0.275 0.381 0.395 0.404 0.456 0.494 0.627 0.713 0.743 0.803 
0.5 0.183 0.268 0.356 0.361 0.353 0.393 0.419 0.542 0.627 0.613 0.682 
0.25 0.231 0.231 0.425 0.343 0.314 0.363 0.373 0.492 0.504 0.505 0.509 
0.125 0.115 0.179 0.240 0.263 0.248 0.271 0.280 0.319 0.341 0.348 0.346 
0 0.095 0.090 0.092 0.092 0.093 0.093 0.092 0.093 0.093 0.093 0.092 
Small Capsule Time (minutes) 
[XG] 
(mg/mL) 15 30 60 75 90 105 120 135 150 165 180 
5 0.326 0.381 0.492 0.587 0.564 0.686 0.736 0.839 0.916 1.009 1.079 
2.5 0.218 0.270 0.366 0.453 0.477 0.585 0.629 0.703 0.737 0.790 0.814 
2 0.177 0.235 0.307 0.357 0.352 0.384 0.398 0.416 0.430 0.443 0.446 
1 0.232 0.234 0.278 0.310 0.320 0.353 0.362 0.377 0.385 0.402 0.412 
0.5 0.183 0.220 0.250 0.270 0.263 0.280 0.286 0.294 0.310 0.324 0.327 
0.25 0.142 0.156 0.165 0.172 0.164 0.169 0.168 0.169 0.168 0.169 0.167 
0.125 0.165 0.196 0.208 0.204 0.204 0.192 0.185 0.183 0.182 0.179 0.177 
0 0.090 0.090 0.090 0.090 0.091 0.091 0.092 0.091 0.091 0.091 0.091 
Large Capsule Time (minutes) 
[XG] 
(mg/mL) 15 30 60 75 90 105 120 135 150 165 180 
5 0.380 0.398 0.424 0.428 0.392 0.437 0.500 0.540 0.530 0.582 0.579 
2.5 0.404 0.387 0.384 0.369 0.351 0.395 0.403 0.451 0.424 0.397 0.414 
2 0.335 0.362 0.381 0.401 0.369 0.390 0.413 0.409 0.407 0.434 0.439 
1 0.381 0.421 0.442 0.497 0.464 0.514 0.535 0.563 0.559 0.583 0.555 
0.5 0.359 0.341 0.334 0.341 0.342 0.359 0.357 0.350 0.350 0.367 0.372 
0.25 0.483 0.490 0.463 0.442 0.447 0.436 0.423 0.401 0.447 0.445 0.449 
0.125 0.410 0.426 0.440 0.470 0.443 0.396 0.376 0.363 0.362 0.361 0.356 
0 0.089 0.089 0.090 0.090 0.089 0.090 0.090 0.090 0.090 0.090 0.090 
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Table A1.2 Concentration (obtained from Absorbance value and Beer-Lambert’s Law) 
 
 
 
  
Free Enzyme Time (minutes) 
[XG] 
(mg/mL) 15 30 60 75 90 105 120 135 150 165 180 
5 0.191 0.186 0.216 0.165 0.226 0.250 0.191 0.186 0.216 0.165 0.226 
2.5 0.077 0.089 0.118 0.111 0.119 0.164 0.077 0.089 0.118 0.111 0.119 
2 0.089 0.106 0.137 0.132 0.129 0.151 0.089 0.106 0.137 0.132 0.129 
1 0.046 0.069 0.096 0.099 0.101 0.114 0.046 0.069 0.096 0.099 0.101 
0.5 0.046 0.067 0.089 0.090 0.089 0.099 0.046 0.067 0.089 0.090 0.089 
0.25 0.058 0.058 0.107 0.086 0.079 0.091 0.058 0.058 0.107 0.086 0.079 
0.125 0.029 0.045 0.060 0.066 0.062 0.068 0.029 0.045 0.060 0.066 0.062 
0 0.024 0.023 0.023 0.023 0.023 0.023 0.024 0.023 0.023 0.023 0.023 
Small Capsule Time (minutes) 
[XG] 
(mg/mL) 15 30 60 75 90 105 120 135 150 165 180 
5 0.082 0.096 0.123 0.147 0.141 0.172 0.082 0.096 0.123 0.147 0.141 
2.5 0.055 0.068 0.092 0.114 0.120 0.147 0.055 0.068 0.092 0.114 0.120 
2 0.044 0.059 0.077 0.090 0.088 0.096 0.044 0.059 0.077 0.090 0.088 
1 0.058 0.059 0.070 0.078 0.080 0.089 0.058 0.059 0.070 0.078 0.080 
0.5 0.046 0.055 0.063 0.068 0.066 0.070 0.046 0.055 0.063 0.068 0.066 
0.25 0.035 0.039 0.041 0.043 0.041 0.042 0.035 0.039 0.041 0.043 0.041 
0.125 0.041 0.049 0.052 0.051 0.051 0.048 0.041 0.049 0.052 0.051 0.051 
0 0.023 0.023 0.023 0.023 0.023 0.023 0.023 0.023 0.023 0.023 0.023 
Large Capsule Time (minutes) 
[XG] 
(mg/mL) 15 30 60 75 90 105 120 135 150 165 180 
5 0.073 0.077 0.084 0.085 0.076 0.087 0.073 0.077 0.084 0.085 0.076 
2.5 0.079 0.075 0.074 0.070 0.066 0.077 0.079 0.075 0.074 0.070 0.066 
2 0.061 0.068 0.073 0.078 0.070 0.075 0.061 0.068 0.073 0.078 0.070 
1 0.073 0.083 0.088 0.102 0.094 0.106 0.073 0.083 0.088 0.102 0.094 
0.5 0.067 0.063 0.061 0.063 0.063 0.068 0.067 0.063 0.061 0.063 0.063 
0.25 0.099 0.100 0.094 0.088 0.089 0.087 0.099 0.100 0.094 0.088 0.089 
0.125 0.080 0.084 0.088 0.095 0.089 0.077 0.080 0.084 0.088 0.095 0.089 
0 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
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Appendix 2. Degradation Study 
A2.1 Chitosan-LV Alginate and Polylysine-LV Alginate Coating 
Low viscosity (LV) alginate (Thermo Fisher; Waltham, MA, USA; A0682, Lot # 
30M017629V), low molecular weight chitosan (Sigma Aldrich; St. Louis, MO, USA,; 
448869-50G, Lot #STBF8219V), acetic acid (Sigma Aldrich; St. Louis, MO, USA; 
34256-1L-R, Lot # SZ8E2510V), and polylysine hydrobromide (polylysine; Sigma 
Aldrich; St. Louis, MO, USA; 81333-50MG, Lot #BCBB0765V) for used for creating 
polymer-coated sensors. Chitosan (1% w/v) was stirred in an acetic acid buffer at pH 
4.0 until completely dissolved. After dissolving, XG and large capsules were transferred 
to the solution and stirred gently for 1 hour to allow the chitosan to adsorb onto the MV 
alginate capsule. After adsorption, the capsules were imaged under phase contrast 
microscopy to verify the presence of a chitosan layer. Afterwards, the chitosan-coated 
beads were transferred to a container holding 1% w/v LV alginate and stirred gently for 
1 hour for additional adsorption. Again, beads were visualized afterwards to verify the 
presence of a chitosan-LV alginate layer. Similarly, polylysine layers were added to 
unmodified alginate capsules by stirring the capsules in a 1 mg/mL solution of 
polylysine for 15 minutes. An additional LV alginate coating was applied as previously 
described. 
 
A2.2 Results 
Redesigns of the Milkguard sensor were created to explore the role of polymer 
degradation in sensor response. Coatings of chitosan and polylysine were applied to 
alginate capsules made of medium viscosity alginate. Further coating of the capsule 
 48 
with light viscosity alginate was also explored. These capsules were designed with the 
consideration of degradation as a major contributor of sensor response. 
 
Figure A2.1. Polymer coated alginate capsules. Left: Chitosan coated alginate capsules. XG is present 
as crystals in the chitosan layer. Layer thickness < 200 µm  Right: Polylysine coated alginate capsules. 
Layer thickness < 12 µm. 
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Appendix 3. Images of Bisected Large Capsules During Incubation 
  
Figure A3.1. Bisected alginate-XG beads at initial stage of incubation. Left: Capsule membrane can be 
seen as circle around periphery of capsule hemisphere. At this time, no blue coloration was seen visually 
Right: Bisected bead examined approximately five minutes after the beginning of incubation. No blue 
coloration was seen. 
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Figure A3.2. Bisected alginate-XG beads after 30 minutes of incubation. Left: Capsule membrane 
began to have slight blue coloration. No free XG was observed in excess solution. Right: Bisected bead 
had slight blue coloration in core. 
 
 
 
Figure A3.3. Bisected alginate-XG beads after 60 minutes of incubation. Left: Entire capsule began to 
have a blue coloration. Right: Blue color change was observed in previously bisected beads.  
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